Overview
Daniel Salzberg is a Nephrologist in Baltimore, Maryland. Dr. Salzberg is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, and Nephrosclerosis. Dr. Salzberg is currently accepting new patients.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
22 S Green St, Baltimore, MD 21201
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Maryland Community Medical Group Inc
Christina Turner is a Nephrologist in Easton, Maryland. Dr. Turner is rated as a Distinguished provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Chronic Kidney Disease, Acute Kidney Failure, End-Stage Renal Disease (ESRD), and Autosomal Dominant Hypocalcemia. Dr. Turner is currently accepting new patients.
Kidney And Hypertension Specialists, PLLC
David Yoo is a Nephrologist in Manassas, Virginia. Dr. Yoo is rated as a Distinguished provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. His top areas of expertise are Acute Kidney Failure, Nephrosclerosis, Renovascular Hypertension, Osteotomy, and Tissue Biopsy. Dr. Yoo is currently accepting new patients.
University Of Maryland Physicians PA
Sarah Khan is a Nephrologist in Baltimore, Maryland. Dr. Khan is rated as an Advanced provider by MediFind in the treatment of Autosomal Dominant Hypocalcemia. Her top areas of expertise are Autosomal Dominant Hypocalcemia, Nephrosclerosis, Renovascular Hypertension, and Hypophosphatemia. Dr. Khan is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- End-Stage Renal Disease (ESRD)Dr. Salzberg isDistinguished. Learn about End-Stage Renal Disease (ESRD).
- Advanced
- Chronic Kidney DiseaseDr. Salzberg isAdvanced. Learn about Chronic Kidney Disease.
- Experienced
- Acute Kidney FailureDr. Salzberg isExperienced. Learn about Acute Kidney Failure.
- Acute Tubular NecrosisDr. Salzberg isExperienced. Learn about Acute Tubular Necrosis.
- Autosomal Dominant HypocalcemiaDr. Salzberg isExperienced. Learn about Autosomal Dominant Hypocalcemia.
- Childhood Hypophosphatasia (HPP)Dr. Salzberg isExperienced. Learn about Childhood Hypophosphatasia (HPP).
- Hypophosphatasia (HPP)Dr. Salzberg isExperienced. Learn about Hypophosphatasia (HPP).
- HypophosphatemiaDr. Salzberg isExperienced. Learn about Hypophosphatemia.